Biomarker panel to elevate prostate cancer diagnostics: Berg
The clinical-stage biotech firm and a number of high-profile partners have collaborated on biomarker technology to deliver a more accurate, less invasive option.
The clinical-stage biotech firm and a number of high-profile partners have collaborated on biomarker technology to deliver a more accurate, less invasive option.
A leader from the home trial services provder says patients’ increasing awareness of clinical research has how trial teams should consider their approach.
The trial tech firm says analysis of trials in low- and middle-income regions reveals that innovative statistical methods could make a huge difference.